A systematic review of drug absorption following bariatric surgery and its theoretical implications

Obesity Reviews

Volumn 11, Issue 1, 2010, Pages 41-50

  Padwal, R ^a   Brocks, D ^a   Sharma, A M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Bariatric surgery; Drug absorption; Systematic review; Therapeutic drug monitoring

Indexed keywords

AMOXICILLIN; AMPICILLIN; CYCLOSPORIN; DIGOXIN; ERYTHROMYCIN; ESTRADIOL; ETHAMBUTOL; ETHOSUXIMIDE; HALOPERIDOL; HYDROCHLOROTHIAZIDE; ISONIAZID; LEVONORGESTREL; NITROFURANTOIN; NORETHISTERONE; NORGESTREL; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PENICILLIN G; PHENAZONE; PHENYTOIN; PROPYLTHIOURACIL; RANITIDINE; RIFAMPICIN; SULFAFURAZOLE; TACROLIMUS; THYROXINE; DRUG;

BARIATRIC SURGERY; DRUG ABSORPTION; DRUG MONITORING; DRUG SOLUBILITY; ENTEROHEPATIC CIRCULATION; HUMAN; HYPOTHYROIDISM; JEJUNOILEAL BYPASS; LOADING DRUG DOSE; REVIEW; SCHIZOPHRENIA; SEIZURE; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TUBERCULOSIS; INTESTINE ABSORPTION; META ANALYSIS; METABOLISM; OBESITY, MORBID; OUTCOME ASSESSMENT; PHYSIOLOGY;

BARIATRIC SURGERY; HUMANS; INTESTINAL ABSORPTION; OBESITY, MORBID; OUTCOME ASSESSMENT (HEALTH CARE); PHARMACEUTICAL PREPARATIONS;

EID: 74049144085     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/j.1467-789X.2009.00614.x     Document Type: Review

References (50)

1. Padwal RS, Lewanczuk RZ. Trends in bariatric surgery in Canada, 1993-2003. CMAJ 2005 172 : 735.
2. Steinbrook R. Surgery for severe obesity. N Engl J Med 2004 350 : 1075 1079.
3. Samuel I, Mason EE, Renquist KE, Huang YH, Zimmerman MB, Jamal M. Bariatric surgery trends: an 18-year report from the International Bariatric Surgery Registry. Am J Surg 2006 192 : 657 662.
4. Flum DR, Khan TV, Dellinger EP. Toward the rational and equitable use of bariatric surgery. JAMA 2007 298 : 1442 1444.
5. Brolin RE. Bariatric surgery and long-term control of morbid obesity. JAMA 2002 288 : 2793 2796.
6. Fujioka K. Follow-up of nutritional and metabolic problems after bariatric surgery. Diabetes Care 2005 28 : 481 484.
7. Miller AD, Smith KM. Medication and nutrient administration considerations after bariatric surgery. Am J Health Syst Pharm 2006 63 : 1852 1857.
8. Lau DCW, Douketis JD, Morrison KM, Hramiak IM. 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children. CMAJ 2007 176 (Suppl. 8 1 117.
9. Maggard MA, Shugarman LR, Suttorp M, Maglione M, Sugerman HJ, Sugarman HJ, Livingston EH, Nguyen NT, Li Z, Mojica WA, Hilton L, Rhodes S, Morton SC, Shekelle PG. Meta-analysis: surgical treatment of obesity. Ann Intern Med 2005 142 : 547 559.
10. Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lönroth H, Näslund I, Olbers T, Stenlöf K, Torgerson J, Agren G, Carlsson LM. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007 357 : 741 752.
11. Narbro K, Agren G, Jonsson E, Näslund I, Sjöström L, Peltonen M, Swedish Obese Subjects Intervention Study. Pharmaceutical costs in obese individuals: comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment: the SOS intervention study. Arch Intern Med 2002 162 : 2061 2069.
12. Norman GR, Streiner DL. PDQ Statistics. Mosby-Year Book, Inc : St. Louis, MO, 1997.
13. Andreasen PB, Dano P, Kirk H, Greisen G. Drug absorption and hepatic drug metabolism in patients with different types of intestinal shunt operation for obesity. A study with phenazone. Scand J Gastroenterol 1977 12 : 531 535.
14. Gubbins PO, Bertch KE. Drug absorption in gastrointestinal disease and surgery. Clin Pharmacokinet 1991 21 : 431 447.
15. Hogben CM, Schenker LS, Tocco DJ, Brodie BB. Absorption of drugs from the stomach II: the human. J Pharmacol Exp Ther 1957 120 : 540 545.
16. Malone M. Altered drug disposition in obesity and after bariatric surgery. Nutr Clin Pract 2003 18 : 131 135.
17. Seaman JS, Bowers SP, Dixon P, Schindler L. Dissolution of common psychiatric medications in a Roux-en-Y gastric bypass model. Psychosomatics 2005 46 : 250 253.
18. Rhode BM, Shustik C, Christou NV, MacLean LD. Iron absorption and therapy after gastric bypass. Obes Surg 1999 9 : 17 21.
19. Horowitz M, Cook DJ, Collins PJ, Harding PE, Hooper MJ, Walsh JF, Shearman DJC. Measurement of gastric emptying after gastric bypass surgery using radionuclides. Br J Surg 2005 69 : 655 657.
20. Naslund E, Gryback P, Hellstrom PM, Jacobsson H, Holst JJ, Theodorsson E, Backman L. Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity. Int J Obes Relat Metab Disord 1997 21 : 387 392.
21. Dowling RH. Intestinal adaptation. N Engl J Med 1973 288 : 520 521.
22. Zhou SF. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 2008 38 : 802 832.
23. Mouly S, Paine MF. P-glycoprotein increases from proximal to distal regions of human small intestine. Pharm Res 2003 20 : 1595 1599.
24. Cheymol G. Effects of obesity on pharmacokinetics implications for drug therapy. Clin Pharmacokinet 2000 39 : 215 231.
25. Green B, Duffull SB. What is the best size descriptor to use for pharmacokinetic studies in the obese? Br J Clin Pharmacol 2004 58 : 119 133.
26. Peterson DI. Phenytoin absorption following jejunoileal bypass. Bull Clin Neurosci 1983 48 : 148 149.
27. Peterson DI, Zweig RW. Absorption of anticonvulsants after jejunoileal bypass. Bull Los Angeles Neurol Soc 1974 39 : 51 55.
28. Bruce RM, Wise L. Tuberculosis after jejunoileal bypass for obesity. Ann Intern Med 1977 87 : 574 576.
29. Polk RE, Tenenbaum M, Kline B. Isoniazid and ethambutol absorption with jejunoileal bypass. Ann Intern Med 1978 89 : 430 431.
30. Harris JO, Wasson KR. Tuberculosis after intestinal bypass operation for obesity. Ann Intern Med 1977 86 : 115 116.
31. Griffiths TM, Thomas P, Campbell IA. Antituberculosis drug levels after jejunoileal bypass. Br J Dis Chest 1982 76 : 286 289.
32. Pickleman JR, Evans LS, Kane JM, Freeark RJ. Tuberculosis after jejunoileal bypass for obesity. JAMA 1975 234 : 744.
33. Magee SR, Shih G, Hume A. Malabsorption of oral antibiotics in pregnancy after gastric bypass surgery. J Am Board Fam Med 2007 20 : 310 313.
34. Chenhsu RY, Wu Y, Katz D, Rayhill S. Dose-adjusted cyclosporine C2 in a patient with jejunoileal bypass as compared to seven other liver ransplant recipients. Ther Drug Monit 2003 25 : 665 670.
35. Knight GC, Macris MP, Duncan JM, Frazier OH, Cooley DA. Cyclosporine A pharmacokinetics in a cardiac allograft recipient with a jejuno-ileal bypass. Transplant Proc 1988 20 : 351 355.
36. Kelley M, Jain A, Orloff M, Wrobble K, Venkataramanan R, Bozorgzadeh A. Change in oral absorption of tacrolimus in a liver transplant recipient after reversal of jejunoileal bypass: a case report. Transplant Proc 2005 37 : 3165 3167.
37. Azizi F, Belur R, Albano J. Malabsorption of thyroid hormones after jejunoileal bypass for obesity. Ann Intern Med 1979 90 : 941 942.
38. Bevan JS, Munro JF. Thyroxine malabsorption following intestinal bypass surgery. Int J Obes 1986 10 : 245 246.
39. Adami GF, Gandolfo P, Esposito M, Scopinaro N. Orally-administered serum ranitidine concentration after biliopancreatic diversion for obesity. Obes Surg 1991 1 : 293 294.
40. Fuller AK, Tingle D, DeVane CL, Scott JA, Stewart RB. Haloperidol pharmacokinetics following gastric bypass surgery. J Clin Psychopharmacol 1986 6 : 376 377.
41. Terry SI, Gould JC, McManus JPA, Prescott LF. Absorption of penicillin and paracetamol after small intestinal bypass surgery. Eur J Clin Pharmacol 1982 23 : 245 248.
42. Prince RA, Pincheira JC, Mason EE, Printen KJ. Influence of bariatric surgery on erythromycin absorption. J Clin Pharmacol 1984 24 : 523 527.
43. Garrett ER, Suverkrup RS, Eberst K, Yost RL, O'Leary JP. Surgically affected sulfisoxazole pharmacokinetics in the morbidly obese. Biopharm Drug Dispos 1981 2 : 329 365.
44. Kampmann JP, Klein H, Lumholtz B, Molholm Hansen JE. Ampicillin and propylthiouracil pharmacokinetics in intestinal bypass patients followed up to a year after operation. Clin Pharmacokinet 1984 9 : 168 176.
45. Kennedy MC, Wade DN. Phenytoin absorption in patients with ileojejunal bypass. Br J Clin Pharmacol 1979 7 : 515 518.
46. Backman L, Beerman B, Groschinsky-Grind M, Halberg D. Malabsorption of hydrochlorothiazide following intestinal shunt surgery. Clin Pharmacokinet 1979 4 : 63 68.
47. Gerson CD, Lowe EH, Lindenbaum J. Bioavailability of digoxin tablets in patients with gastrointestinal dysfunction. Am J Med 1980 69 : 43 49.
48. Marcus FI, Quinn EJ, Horton H, Jacobs S, Pippin S, Stafford M, Zukoski C. The effect of jejunoileal bypass on the pharmacokinetics of digoxin in man. Circulation 1977 55 : 537 541.
49. Andersen AN, Lebech PE, Sorensen TIA, Borggaard B. Sex hormone levels and intestinal absorption of estradiol and D-norgestrel in women following bypass surgery for morbid obesity. Int J Obes 1982 6 : 91 96.
50. Victor A, Odlind V, Kral JG. Oral contraceptive absorption and sex hormone binding globulins in obese women: effects of jejunoileal bypass. Gastroenterol Clin North Am 1987 16 : 483 491.